financetom
Business
financetom
/
Business
/
Market Chatter: JPMorgan CEO Jamie Dimon Not Ruling Out Stagflation in US
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: JPMorgan CEO Jamie Dimon Not Ruling Out Stagflation in US
May 26, 2025 12:24 PM

07:45 AM EDT, 05/22/2025 (MT Newswires) -- JPMorgan Chase ( JPM ) Chief Executive Jamie Dimon is not ruling out that the US could fall into stagflation as it faces ongoing geopolitical and fiscal risks, Bloomberg reported Thursday, citing an interview with the CEO.

Dimon said he agreed with the Federal Reserve's recent decision to hold steady on rates.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novo Nordisk confident of amycretin obesity drug launch this decade
Novo Nordisk confident of amycretin obesity drug launch this decade
Mar 8, 2024
BAGSVAERD, Denmark (Reuters) - Novo Nordisk is very comfortable it will be able to launch the pill version of its experimental weight loss drug amycretin this decade, the drugmaker's head of development told Reuters on Friday, a day after it announced strong early trial data on it. I never commit to timelines but I would be very comfortable to say...
Shockwave Medical Insider Sold Shares Worth $507,294, According to a Recent SEC Filing
Shockwave Medical Insider Sold Shares Worth $507,294, According to a Recent SEC Filing
Mar 8, 2024
08:00 AM EST, 03/08/2024 (MT Newswires) -- Frank T Watkins, Director, on March 06, 2024, sold 2,000 shares in Shockwave Medical ( SWAV ) for $507,294. Following the Form 4 filing with the SEC, Watkins has control over a total of 4,532 shares of the company, with 4,532 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000075/xslF345X03/wk-form4_1709864771.xml Price: 261.95, Change: +5.84, Percent Change:...
Why Branded Footwear Retailer Genesco's Shares Are Tumbling Today
Why Branded Footwear Retailer Genesco's Shares Are Tumbling Today
Mar 8, 2024
Genesco Inc shares are plummeting after reporting fourth-quarter FY24 sales growth of 2% year-on-year to $738.95 million, beating the analyst consensus estimate of $705.66 million. Excluding the 14th week, sales would have decreased 2% for the fourth quarter of fiscal 2024. Total comparable sales declined 4%. Overall sales dropped 2% at Journeys, grew 6% at Schuh, up 9% at Johnston & Murphy,...
Ani Pharmaceuticals Insider Sold Shares Worth $2,630,864, According to a Recent SEC Filing
Ani Pharmaceuticals Insider Sold Shares Worth $2,630,864, According to a Recent SEC Filing
Mar 8, 2024
08:09 AM EST, 03/08/2024 (MT Newswires) -- Muthusamy Shanmugam, Director, HEAD OF R&D, COO-NOVITIUM OPS, around March 05, 2024, sold 40,000 shares in Ani Pharmaceuticals ( ANIP ) for $2,630,864. Following the Form 4 filing with the SEC, Shanmugam has control over a total of 916,272 shares of the company, with 68,652 shares held directly and 847,620 shares controlled indirectly....
Copyright 2023-2026 - www.financetom.com All Rights Reserved